skip to content

Cambridge Biosciences DTP PhD Programme


The Cambridge Biosciences Doctoral Training Partnership (DTP) is a partnership between four internationally leading research organisations — the University of Cambridge, the Babraham Institute, the National Institute of Agricultural Botany, and the Wellcome Sanger Institute — and UKRI BBSRC to develop the next generation of bioscience talent.

The Life Sciences are key to addressing many of the current societal and global challenges, and PhD-trained bioscientists are needed to meet the demands of the thriving and expanding bioeconomy. Our DTP addresses this need by providing a welcoming and vibrant training environment in which talented and motivated students from diverse backgrounds undertake cutting edge research projects and become equipped for a range of careers in academia, industry, government and charitable sectors.

Our students benefit from our location at the heart of Europe’s largest cluster of bioscience companies and enjoy opportunities to interact with a range of external organisations. Our DTP, via internships and iCASE studentships, also provides a convenient entry point for external organisations to forge collaboration with researchers across our partnership.

Available Studentships

Applications for this year are closed. The next application round will open in October 2022

Latest news

Cambridge Biosciences DTP Symposium 2022

26 July 2022

On Monday 25 July the Cambridge Biosciences DTP hosted another successful Annual DTP Student Symposium at Robinson College!

DTP Student, Jack Marcus Smith, featured on BBC Springwatch

11 July 2022

Our DTP Student, Jack Marcus Smith, was recently featured on BBC Springwatch. Jack is currently on the last year of his PhD in the Department of Zoology.

'Masked' cancer-killing drugs avoid harming healthy cells – new research from our alumna Dr Lavinia Dunsmore

6 July 2022

A new methodology, developed by our Cambridge Biosciences DTP alumna, Dr Lavinia Dunsmore, during her PhD, has created a way to avoid the toxicity of some plant-derived cancer-killing drugs by 'masking' their toxicity until they reach their targets, potentially leading to more effective cancer therapies. Using the new...